Personalized medicine: Selective therapy

A forum to discuss research on the origins of MS and its development.

Personalized medicine: Selective therapy

Postby frodo » Tue Jul 10, 2018 2:06 am

Here there is a freely available review about the state-of-the-art as it was 2 years ago. ... 8516672017

Personalised medicine for multiple sclerosis care


Treatments with a range of efficacy and risk of adverse events have become available for the management of multiple sclerosis (MS). However, now the heterogeneity of clinical expression and responses to treatment pose major challenges to improving patient care.

Selecting and managing the drug best balancing benefit and risk demands a new focus on the individual patient. Personalised medicine for MS is based on improving the precision of diagnosis for each patient in order to capture prognosis and provide an evidence-based framework for predicting treatment response and personalising patient monitoring. It involves development of predictive models involving the integration of clinical and biological data with an understanding of the impact of disease on the lives of individual patients.

Here, we provide a brief, selective review of challenges to personalisation of the management of MS and suggest an agenda for stakeholder engagement and research to address them.
User avatar
Family Elder
Posts: 1149
Joined: Wed Dec 02, 2009 3:00 pm


Return to MS Etiology and Pathogenesis


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service